Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-25

Clinical Trial Update: Retrospective Clinical Validation of HepatoPredict

View source ↗

Summary

Retrospective clinical validation study of HepatoPredict by Ophiomics, with hepatocellular carcinoma as the primary condition; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HepatoPredict

Snippet

Sponsor: Ophiomics | Conditions: Hepato Cellular Carcinoma (HCC), Liver Resection | Status: NOT_YET_RECRUITING